To evaluate drug expenditure in healthcare, Vizient collected medication spend data from its pharmacy program clients, including hospital, non-acute and pediatric care providers. The information below spans from April 2023 to March 2024.
The top 10 infectious disease treatments by spend, along with their approved indications:
1. Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) — HIV-1
2. Prevnar 20 (pneumococcal 20-valent vaccine) — Prevention of pneumococcal disease
3. Veklury (remdesivir) — COVID-19
4. Gardasil 9 (human papillomavirus vaccine, 9-valent vaccine) — Prevention of HPV disease
5. Epclusa (sofosbuvir/velpatasvir) — Hepatitis C
6. Xifaxan (rifaximin) — Traveler’s diarrhea, hepatic encephalopathy
7. Shingrix — Prevention of herpes zoster
8. Mavyret (glecaprevir/pibrentasvir) — Hepatitis C
9. Boostrix — Prevention of diphtheria, pertussis, tetanus
10. Ambisome (amphotericin B liposome) — Fungal infections
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
